Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: craig crawford who wrote (106041)	6/1/2001 6:44:44 PM
From: benwood	Respond to of 436258

I think the funny thing is that if it weren't for insurance, those without insurance could afford the prescriptions they need. You get virtually no comparison shopping if it's covered by a plan, so most of the fighting is between drug companies and insurance companies, with the millions of people w/o insurance as the losers. Then there's the patent extension games... one drug expires, just as a new "improved" version comes out, with the requisite pandering to Dr's to make sure that the "old" drug is never prescribed again (for which there would soon be a generic). Craig, I agree that drugs are vastly overused (like Ritalin); however, there are some wonderful new drugs out there for things like Multiple Sclerosis that are very expensive. For some things, you only have access to the symptoms. But there is much that can be done cheaply for most people and many refuse to do what's right for their body.